Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGF Hydrogel for Oral Mucositis in Head and Neck Cancer
NCT04995354Phase 3Unknown
- Sponsor
- Cairo University
- Start
- Jun 2022
- Primary completion
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of nepidermin in oral mucositis (OM), sponsored by Cairo University. Status: unknown.
02
Drugs
nepidermin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT04995354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04995354.